A Randomized Controlled Trial to Evaluate Antiretroviral Salvage Therapy Guided by Rules-Based or Phenotype-Driven HIV-1 Genotypic Drug-Resistance Interpretation With or Without Concentration-Controlled Intervention: The Resistance and Dosage Adapted Regimens (RADAR) Study
2005-01-01 Carlo, Torti; Eugenia, Quiros‐roldan; Mario, Regazzi; Andrea De, Luca; Francesco, Mazzotta; Andrea, Antinori; Nicoletta, Ladisa; Valeria, Micheli; Anna, Orani; Andrea, Patroni; Paola, Villani; Lo Caputo, S; Francesca, Moretti; Simona Di, Giambenedetto; Filippo, Castelnuovo; Paolo, Maggi; Carmine, Tinelli; Giampiero, Carosi; and the RADAR-MASTER Study, Group
An evolutionary analysis of antigen processing and presentation across different timescales reveals pervasive selection.
2014-01-01 Forni, D; Cagliani, R; Tresoldi, C; Pozzoli, U; De Gioia, L; Filippi, G; Riva, S; Menozzi, G; Colleoni, M; Biasin, M; Lo Caputo, S; Mazzotta, F; Comi, Gp; Bresolin, N; Clerici, M; Sironi, M
Human [alpha] Defensin in HIV-Exposed But Uninfected Individuals
2004-01-01 Trabattoni, ; Daria, ; Lo Caputo, S; Maffeis, ; Giada, ; Vichi, ; Francesca, ; Biasin, ; Mara, ; Pierotti, ; Piera, ; Fasano, ; Francesca, ; Saresella, ; Marina, ; Franchini, ; Mario, ; Ferrante, ; Pasquale, ; Mazzotta, ; Francesco, ; Clerici, ; Mario,
Human Immunodeficiency Virus (HIV)–Specific IgA and HIV Neutralizing Activity in the Serum of Exposed Seronegative Partners of HIV‐Seropositive Persons
1999-01-01 Sandra, Mazzoli; Lucia, Lopalco; Alessandra, Salvi; Daria, Trabattoni; Lo Caputo, S; Francesca, Semplici; Mara, Biasin; Claudio, Blé; Antonio, Cosma; Claudia, Pastori; Francesca, Meacci; Francesco, Mazzotta; Maria Luisa, Villa; Antonio G., Siccardi; and Mario, Clerici
Clinical validation and applicability of different tipranavir/ritonavir genotypic scores in HIV-1 protease inhibitor-experienced patients
2009-01-01 Saracino, A; Monno, L; Tartaglia, A; Tinelli, C; Seminari, E; Maggiolo, F; Bonora, S; Rusconi, S; Micheli, V; Lo Caputo, S; Lazzaroni, L; Ferrara, S; Ladisa, N; Nasta, P; Parruti, G; Bellagamba, R; Forbici, F; Angarano, G
A role for mucosal immunity in resistance to HIV infection
1999-01-01 Clerici, M; Salvi, A; Trabattoni, D; Lo Caputo, S; Semplici, F; Biasin, M; Ble, C; Meacci, F; Romeo, C; Piconi, S; Mazzotta, F; Villa, Ml; Mazzoli, S
An intricate case of multidrug resistant Plasmodium falciparum isolate imported from Cambodia.
2017-01-01 Dell'Acqua, R; Fabrizio, C; Di Gennaro, F; Lo Caputo, S; Saracino, A; Menegon, M; L'Episcopia, M; Severini, C; Monno, L; Castelli, F; Angarano, G
Durability of Second Antiretroviral Regimens in the Italian Cohort Naive Antiretrovirals Foundation Study and Factors Associated with Discontinuation
2017-01-01 Di Biagio, A; Lorenzini, P; Gustinetti, G; Rusconi, S; De Luca, A; Lapadula, G; Lo Caputo, S; Cicalini, S; Castelli, F; Marchetti, G; Antinori, A; Monforte, Ad
Genotypes at chromosome 22q12-13 are associated with HIV-1-exposed but uninfected status in Italians
2005-01-01 Kanari, ; Yasuyoshi, ; Clerici, ; Mario, ; Abe, ; Hiroyuki, ; Kawabata, ; Hiroyuki, ; Trabattoni, ; Daria, ; Lo Caputo, S; Mazzotta, ; Francesco, ; Fujisawa, ; Hironori, ; Niwa, ; Atsuko, ; Ishihara, ; Chiaki, ; Takei, ; Yumiko, A; Miyazawa, ; Masaaki,
Genetic variability at the TREX1 locus is not associated with natural resistance to HIV-1 infection
2012-01-01 Sironi, M; Biasin, M; Forni, D; Cagliani, R; De Luca, M; Saulle, I; Lo Caputo, S; Mazzotta, F; Macias, J; Pineda, Ja; Caruz, A; Clerici, M
Early virological failure after tenofovir + didanosine + efavirenz combination in HIV-positive patients upon starting antiretroviral therapy
2005-01-01 Torti, C; Quiros-Roldon, E; Regazzi, M; Antinori, A; Patroni, A; Villani, P; Tirelli, V; Cologni, G; Zinzi, D; Lo Caputo, S; Perini, P; Carosi, G; KARINA-SISTHER Collaboration Group of the MASTER, Cohort.
Increased risk of virologic failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: data from the ICONA cohort
2016-01-01 Saracino, A; Lorenzini, P; Lo Caputo, S; Girardi, E; Castelli, F; Bonfanti, P; Rusconi, S; Caramello, P; Abrescia, N; Mussini, C; Monno, L; d'Arminio Monforte, A; ICONA Foundation Study, Group
. Incidence and risk factors for liver enzyme elevation during highly active antiretroviral therapy in HIV-HCV co-infected patients: results from the Italian EPOKA-MASTER Cohort.
2005-01-01 Torti, C; Lapadula, G; Casari, S; Puoti, M; Nelson, M; Quiros-Roldan, E; Bella, D; Pastore, G; Ladisa, N; Minoli, L; Sotgiu, G; Mazzotta, F; Lo Caputo, S; Di Perri, G; Filice, G; Tinelli, C; Carosi, G; EPOKA-MASTER Study, Group.
Twenty Years Later: the Recent Trends of HIV-infection – Evidence from an Italian Region
2007-01-01 L., Monno; S., Carbonara; E., Ciracì; N., Ladisa; Lo Caputo, S; G., Punzi; A. De Silvestri and G., Angarano
Characterization of viro-immunological responses in a closely followed cohort of heavily pretreated patients: evidence from the GenPheRex Study
2003-01-01 Torti, C; Quiros-Roldan, E; Scudeller, L; Lo Caputo, S; Tomasoni, L; Castelli, F; Poggio, A; Delle Foglie, P; Chirianni, A; Sighinolfi, L; Mazzotta, F; Carosi, G; GenPheRex Group of the, Ma. S. Te. R. Cohort.
Prevalence of hepatitis virus infections in Albanian refugees
1993-01-01 Santantonio, T; Lo Caputo, S; Germinario, C; Squarcione, S; Greco, D; Laddago, V; Pastore, G
Durability and tolerability of first-line regimens including two nucleoside reverse transcriptase inhibitors and raltegravir or ritonavir boosted-atazanavir or -darunavir: data from the ICONA Cohort
2018-01-01 d'Arminio Monforte, A; Lorenzini, P; Cozzi-Lepri, A; Mussini, C; Castagna, A; Baldelli, F; Puoti, M; Vichi, F; Maddaloni, A; Lo Caputo, S; Gianotti, N; Antinori, A; on behalf of the Icona Foundation Study, Group
Anti-nef antibodies and other predictors of disease progression in HIV-1 seropositive injecting drug users
1992-01-01 Rezza, G; Titti, F; Pezzotti, P; Sernicola, L; Lo Caputo, S; Angarano, G; Lazzarin, A; Sinicco, A; Rossi, Gb; Verani, P.
Real Versus Virtual Phenotype to Guide Treatment in Heavily Pretreated Patients: 48-Week Follow-Up of the Genotipo-Fenotipo di Resistenza (GenPheRex) Trial
2003-01-01 Mazzotta, ; Francesco, ; Lo Caputo, S; Torti, ; Carlo, ; Tinelli, ; Carmine, ; Pierotti, ; Piera, ; Castelli, ; Francesco, ; Lazzarin, ; Adriano, ; Angarano, ; Gioacchino, ; Maserati, ; Renato, ; Gianotti, ; Nicola, ; Ladisa, ; Nicoletta, ; Quiros-Roldan, ; Eugenia, ; Rinehart, ; Alex, R.; Carosi, ; Giampiero, ; Genotipo-Fenotipo di Resistenza (GenPheRex) Group of the Italian Management Standardizzato di Terapia Antiretrovirale (MASTER), Cohort
Seroimmunity to poliomyelitis in an Albanian immigrant population
1992-01-01 Squarcione, S; Germinario, C; Iandolo, E; Lo Caputo, S; Bergamini, F; Profeta, Ml; Greco, D; Quarto, M; Barbuti, S
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A Randomized Controlled Trial to Evaluate Antiretroviral Salvage Therapy Guided by Rules-Based or Phenotype-Driven HIV-1 Genotypic Drug-Resistance Interpretation With or Without Concentration-Controlled Intervention: The Resistance and Dosage Adapted Regimens (RADAR) Study | 1-gen-2005 | Carlo, Torti; Eugenia, Quiros‐roldan; Mario, Regazzi; Andrea De, Luca; Francesco, Mazzotta; Andrea, Antinori; Nicoletta, Ladisa; Valeria, Micheli; Anna, Orani; Andrea, Patroni; Paola, Villani; Lo Caputo, S; Francesca, Moretti; Simona Di, Giambenedetto; Filippo, Castelnuovo; Paolo, Maggi; Carmine, Tinelli; Giampiero, Carosi; and the RADAR-MASTER Study, Group | |
| An evolutionary analysis of antigen processing and presentation across different timescales reveals pervasive selection. | 1-gen-2014 | Forni, D; Cagliani, R; Tresoldi, C; Pozzoli, U; De Gioia, L; Filippi, G; Riva, S; Menozzi, G; Colleoni, M; Biasin, M; Lo Caputo, S; Mazzotta, F; Comi, Gp; Bresolin, N; Clerici, M; Sironi, M | |
| Human [alpha] Defensin in HIV-Exposed But Uninfected Individuals | 1-gen-2004 | Trabattoni, ; Daria, ; Lo Caputo, S; Maffeis, ; Giada, ; Vichi, ; Francesca, ; Biasin, ; Mara, ; Pierotti, ; Piera, ; Fasano, ; Francesca, ; Saresella, ; Marina, ; Franchini, ; Mario, ; Ferrante, ; Pasquale, ; Mazzotta, ; Francesco, ; Clerici, ; Mario, | |
| Human Immunodeficiency Virus (HIV)–Specific IgA and HIV Neutralizing Activity in the Serum of Exposed Seronegative Partners of HIV‐Seropositive Persons | 1-gen-1999 | Sandra, Mazzoli; Lucia, Lopalco; Alessandra, Salvi; Daria, Trabattoni; Lo Caputo, S; Francesca, Semplici; Mara, Biasin; Claudio, Blé; Antonio, Cosma; Claudia, Pastori; Francesca, Meacci; Francesco, Mazzotta; Maria Luisa, Villa; Antonio G., Siccardi; and Mario, Clerici | |
| Clinical validation and applicability of different tipranavir/ritonavir genotypic scores in HIV-1 protease inhibitor-experienced patients | 1-gen-2009 | Saracino, A; Monno, L; Tartaglia, A; Tinelli, C; Seminari, E; Maggiolo, F; Bonora, S; Rusconi, S; Micheli, V; Lo Caputo, S; Lazzaroni, L; Ferrara, S; Ladisa, N; Nasta, P; Parruti, G; Bellagamba, R; Forbici, F; Angarano, G | |
| A role for mucosal immunity in resistance to HIV infection | 1-gen-1999 | Clerici, M; Salvi, A; Trabattoni, D; Lo Caputo, S; Semplici, F; Biasin, M; Ble, C; Meacci, F; Romeo, C; Piconi, S; Mazzotta, F; Villa, Ml; Mazzoli, S | |
| An intricate case of multidrug resistant Plasmodium falciparum isolate imported from Cambodia. | 1-gen-2017 | Dell'Acqua, R; Fabrizio, C; Di Gennaro, F; Lo Caputo, S; Saracino, A; Menegon, M; L'Episcopia, M; Severini, C; Monno, L; Castelli, F; Angarano, G | |
| Durability of Second Antiretroviral Regimens in the Italian Cohort Naive Antiretrovirals Foundation Study and Factors Associated with Discontinuation | 1-gen-2017 | Di Biagio, A; Lorenzini, P; Gustinetti, G; Rusconi, S; De Luca, A; Lapadula, G; Lo Caputo, S; Cicalini, S; Castelli, F; Marchetti, G; Antinori, A; Monforte, Ad | |
| Genotypes at chromosome 22q12-13 are associated with HIV-1-exposed but uninfected status in Italians | 1-gen-2005 | Kanari, ; Yasuyoshi, ; Clerici, ; Mario, ; Abe, ; Hiroyuki, ; Kawabata, ; Hiroyuki, ; Trabattoni, ; Daria, ; Lo Caputo, S; Mazzotta, ; Francesco, ; Fujisawa, ; Hironori, ; Niwa, ; Atsuko, ; Ishihara, ; Chiaki, ; Takei, ; Yumiko, A; Miyazawa, ; Masaaki, | |
| Genetic variability at the TREX1 locus is not associated with natural resistance to HIV-1 infection | 1-gen-2012 | Sironi, M; Biasin, M; Forni, D; Cagliani, R; De Luca, M; Saulle, I; Lo Caputo, S; Mazzotta, F; Macias, J; Pineda, Ja; Caruz, A; Clerici, M | |
| Early virological failure after tenofovir + didanosine + efavirenz combination in HIV-positive patients upon starting antiretroviral therapy | 1-gen-2005 | Torti, C; Quiros-Roldon, E; Regazzi, M; Antinori, A; Patroni, A; Villani, P; Tirelli, V; Cologni, G; Zinzi, D; Lo Caputo, S; Perini, P; Carosi, G; KARINA-SISTHER Collaboration Group of the MASTER, Cohort. | |
| Increased risk of virologic failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: data from the ICONA cohort | 1-gen-2016 | Saracino, A; Lorenzini, P; Lo Caputo, S; Girardi, E; Castelli, F; Bonfanti, P; Rusconi, S; Caramello, P; Abrescia, N; Mussini, C; Monno, L; d'Arminio Monforte, A; ICONA Foundation Study, Group | |
| . Incidence and risk factors for liver enzyme elevation during highly active antiretroviral therapy in HIV-HCV co-infected patients: results from the Italian EPOKA-MASTER Cohort. | 1-gen-2005 | Torti, C; Lapadula, G; Casari, S; Puoti, M; Nelson, M; Quiros-Roldan, E; Bella, D; Pastore, G; Ladisa, N; Minoli, L; Sotgiu, G; Mazzotta, F; Lo Caputo, S; Di Perri, G; Filice, G; Tinelli, C; Carosi, G; EPOKA-MASTER Study, Group. | |
| Twenty Years Later: the Recent Trends of HIV-infection – Evidence from an Italian Region | 1-gen-2007 | L., Monno; S., Carbonara; E., Ciracì; N., Ladisa; Lo Caputo, S; G., Punzi; A. De Silvestri and G., Angarano | |
| Characterization of viro-immunological responses in a closely followed cohort of heavily pretreated patients: evidence from the GenPheRex Study | 1-gen-2003 | Torti, C; Quiros-Roldan, E; Scudeller, L; Lo Caputo, S; Tomasoni, L; Castelli, F; Poggio, A; Delle Foglie, P; Chirianni, A; Sighinolfi, L; Mazzotta, F; Carosi, G; GenPheRex Group of the, Ma. S. Te. R. Cohort. | |
| Prevalence of hepatitis virus infections in Albanian refugees | 1-gen-1993 | Santantonio, T; Lo Caputo, S; Germinario, C; Squarcione, S; Greco, D; Laddago, V; Pastore, G | |
| Durability and tolerability of first-line regimens including two nucleoside reverse transcriptase inhibitors and raltegravir or ritonavir boosted-atazanavir or -darunavir: data from the ICONA Cohort | 1-gen-2018 | d'Arminio Monforte, A; Lorenzini, P; Cozzi-Lepri, A; Mussini, C; Castagna, A; Baldelli, F; Puoti, M; Vichi, F; Maddaloni, A; Lo Caputo, S; Gianotti, N; Antinori, A; on behalf of the Icona Foundation Study, Group | |
| Anti-nef antibodies and other predictors of disease progression in HIV-1 seropositive injecting drug users | 1-gen-1992 | Rezza, G; Titti, F; Pezzotti, P; Sernicola, L; Lo Caputo, S; Angarano, G; Lazzarin, A; Sinicco, A; Rossi, Gb; Verani, P. | |
| Real Versus Virtual Phenotype to Guide Treatment in Heavily Pretreated Patients: 48-Week Follow-Up of the Genotipo-Fenotipo di Resistenza (GenPheRex) Trial | 1-gen-2003 | Mazzotta, ; Francesco, ; Lo Caputo, S; Torti, ; Carlo, ; Tinelli, ; Carmine, ; Pierotti, ; Piera, ; Castelli, ; Francesco, ; Lazzarin, ; Adriano, ; Angarano, ; Gioacchino, ; Maserati, ; Renato, ; Gianotti, ; Nicola, ; Ladisa, ; Nicoletta, ; Quiros-Roldan, ; Eugenia, ; Rinehart, ; Alex, R.; Carosi, ; Giampiero, ; Genotipo-Fenotipo di Resistenza (GenPheRex) Group of the Italian Management Standardizzato di Terapia Antiretrovirale (MASTER), Cohort | |
| Seroimmunity to poliomyelitis in an Albanian immigrant population | 1-gen-1992 | Squarcione, S; Germinario, C; Iandolo, E; Lo Caputo, S; Bergamini, F; Profeta, Ml; Greco, D; Quarto, M; Barbuti, S |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista31194
- 4 Contributo in Atti di Convegno ...3
Data di pubblicazione
- In corso di stampa38
- 2020 - 20269147
- 2010 - 201911286
- 2000 - 20096752
- 1990 - 19992845
- 1980 - 1989901
- 1970 - 1979224
- 1967 - 19693
Editore
- Lippincott, Williams & Wilkins:53...116
- Giuffre Editore Spa:via Busto Ars...112
- Elsevier Science Limited:Oxford F...106
- Elsevier BV:PO Box 211, 1000 AE A...103
- Blackwell Munksgaard:PO Box 2148,...93
- Blackwell Science Limited:PO Box ...91
- Edizioni Minerva Medica:Corso Bra...74
- Chiriotti Editori Spa:PO Box 66, ...70
- W B Saunders Company:Fulfillment ...69
- Springer Verlag Germany:Tiergarte...65
Rivista
- PHYSICAL REVIEW LETTERS267
- PHYSICS LETTERS. SECTION B182
- JOURNAL OF CLINICAL MEDICINE169
- INTERNATIONAL JOURNAL OF MOLECULA...166
- PHYSICAL REVIEW D, PARTICLES, FIE...161
- ACTA HORTICULTURAE159
- INTERNATIONAL JOURNAL OF CARDIOLOGY145
- PLOS ONE138
- JOURNAL OF BIOLOGICAL REGULATORS ...127
- LA RADIOLOGIA MEDICA126
Keyword
- Humans1202
- Male648
- Female591
- Middle Aged399
- Adult327
- Aged325
- Italy294
- COVID-19248
- Animals221
- Medicine (all)160
Lingua
- eng18110
- ita5543
- spa132
- fre99
- ger44
- lat30
- grc27
- enm19
- por18
- pol5
Accesso al fulltext
- no fulltext30726
- open363
- restricted77
- reserved29
- partially open1